NYSE: IVZ · Asset Management
Invesco (IVZ) fair value: undervalued or overvalued?
As of 16 Nov 2026, Faircurve's model values Invesco (IVZ) at $36.01 a share. The stock last closed at $28.49, which puts the model's fair value 26.4% above the price. On the model's bands that reads as Undervalued.
Revalued . Price is the close of 16 Nov 2026. Invesco Ltd.
The report adds the live price, the chart against the range the options market prices, the next earnings date and the analysts' consensus. No account needed.
This week, in three parts
What happenedThe run of 16 Nov 2026 moved the fair value from $32.58 to $36.01 (+10.5%).
What the model makes of itThe price of $28.49 is 26.4% below it: Undervalued, on a medium evidence grade.
What's nextReports on 26 Jan 2027. Options prices imply a move of about 11% either way over the next month. The next weekly run is on Saturday 21 Nov 2026.
What price range does the model give IVZ?
The calibrated range for IVZ over 63 trading days is $25.16 to $32.46. It sits around the last close, and its width comes from the volatility that IVZ's own options imply (38% a year), calibrated weekly against realised prices (n = 8,038 past valuations, refreshed 14 Nov 2026). Ranges built this way held the price 60% of the time at this horizon. The fair value is the model's opinion and rides beside the range. It is not the centre of it.
The model's own simulated range, from the 20th to the 80th percentile of its runs, is $24.97 to $51.02. In 68% of the simulations the fair value came out above the price the model ran on.
Faircurve Insights · 16 Nov 2026
Invesco Ltd. (IVZ) is an asset manager in financial services. It engages in the investment management business, with products that include mutual funds, unit trusts, exchange-traded funds, closed-end funds and retirement plans.
Faircurve's model put the fair value at $36.01 a share on 16 Nov 2026, the midpoint of 2,000 simulations. That is up 10.5% from $32.58 at the previous run, on 7 Nov 2026. The calibrated range over 63 trading days runs from $25.59 to $32.88. It is built from the volatility the stock's own options imply and calibrated weekly against realised prices, using 8,038 past valuations refreshed on 14 Nov 2026. Ranges built this way held the price 60% of the time at this horizon. The evidence grade is Medium. The grade looks at inputs, comparable companies and the spread of outcomes. It does not say whether the fair value is right.
The business scores 39 out of 100 on the model's overall quality measure against comparable companies. Earnings quality stands out at 86. Profitability is 14, with ROIC at -1.5% against a peer median of 7.0%. Growth quality is 27, with trailing revenue growth of 5.1% against a peer median of 19.8%. The model compares it with SEI Investments (SEIC), Equitable Holdings (EQH), Affiliated Managers Group (AMG), Franklin Resources (BEN), Victory Capital (VCTR), T. Rowe Price (TROW) and Principal Financial Group (PFG).
Written from the figures on this page for the 16 Nov 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
The Global Pulse
Faircurve's note after each US session, in your inbox. No account needed.
When does IVZ report earnings, and how has the stock reacted?
Invesco's next earnings report is scheduled for 26 Jan 2027. Companies can move their dates.
Options prices on 16 Nov 2026 imply a move of about 8.8% in either direction through the nearest expiry, about 31 days out. That is the size the market is pricing, not a direction. IVZ's 30 day implied volatility works out to about 10.9% over one month.
Around its last 8 reports: what the options market priced, and what followed
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across IVZ's last 8 reports, ignoring direction, was 4.9%.
What the options market has priced for a month's move in IVZ
How does IVZ score on business quality?
Invesco's overall quality score is 39 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.
| Factor | Score (0 to 100) | Headline measure | Peer median |
|---|---|---|---|
| ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend. | 14 | -1.5%ROIC | 7.0% |
| Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash). | 86 | ||
| Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analysts' rating changes. | 27 | 5.1%Revenue growth, trailing | 19.8% |
| Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks. | 29 | 1.7%Net buybacks / market value | 2.7% |
| Balance sheetNet debt to EBITDA and interest coverage. | 70 | -1.80xNet debt / EBITDA | 2.67x |
| StabilityDownside volatility of the EBITDA margin over the last five years. | 23 | 12.2 ptsEBITDA margin downside volatility, 5y | 5.1 pts |
How does IVZ compare with similar companies?
The companies in asset management closest to Invesco in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| SEIC SEI Investments Company | $108.13 | $107.62 | -0.5% | Fairly valued |
| CG The Carlyle Group Inc. | $38.62 | $36.30 | -6.0% | Low evidence grade |
| EQH Equitable Holdings, Inc. | $55.28 | $58.83 | +6.4% | Fairly valued |
| AMG Affiliated Managers Group, Inc. | $387.60 | $531.36 | +37.1% | Undervalued |
| BEN Franklin Resources, Inc. | $35.01 | $34.17 | -2.4% | Fairly valued |
| VCTR Victory Capital Holdings, Inc. | $119.99 | $137.33 | +14.5% | Fairly valued |
| TROW T. Rowe Price Group, Inc. | $107.96 | $132.47 | +22.7% | Undervalued |
| PFG Principal Financial Group, Inc. | $112.27 | $111.97 | -0.3% | Fairly valued |
What the comparable companies' multiples alone would give for IVZ, the peer-implied price, is $52.47 a share on this run. The fair value weighs that against the company's own multiple.
Invesco at a glance
Invesco Ltd. engages in the investment management business. Its products include mutual funds, unit trusts, exchange-traded funds, closed-end funds, and retirement plans. The company was founded in December 1935 and is headquartered in Atlanta, GA.
- Market value
- $12.7B
- Sector
- Financial Services
- Industry
- Asset Management
- Revenue expected, next twelve months
- $5.7B
- Consensus revenue growth, next fiscal year
- -15.8%
- Analysts with estimates
- 8
- Beta to the US market
- 1.83
- First valued by Faircurve
- 4 Jul 2026
At the close of 16 Nov 2026, 56.8% of the 1,085 graded US stocks the model covers traded below the model's fair value. IVZ was among them.
How the fair value is worked out: the model prices Invesco on the value of the whole business, debt included, against the operating profit analysts expect next year (forward EV/EBITDA), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.
What changed in the latest valuation?
On 7 Nov 2026 the model's fair value for IVZ was $32.58. As of 16 Nov 2026 it is $36.01, a change of +10.5%. The model revalues every stock it covers each week, and again after an earnings report.
Questions about Invesco's valuation
Is Invesco stock undervalued or overvalued?
On Faircurve's model, IVZ reads as Undervalued as of 16 Nov 2026. The model's fair value is $36.01 a share against a last close of $28.49, a gap of +26.4%.
What is IVZ's fair value?
$36.01 a share as of 16 Nov 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $24.97 to $51.02.
What price range does the model give IVZ?
$25.16 to $32.46 over 63 trading days. Ranges built this way held the price 60% of the time across 8,038 past valuations, refreshed 14 Nov 2026.
When does Invesco report earnings next?
The next report is scheduled for 26 Jan 2027. Companies can move their dates.
How much has IVZ moved on past earnings reports?
Across its last 8 reports the median two session move was 4.9%, ignoring direction. The largest was +8.4% around the report of 22 Apr 2025.
How confident is the model in this valuation?
The model's evidence grade for IVZ is medium. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.
The model's own ideas on IVZ
The model holds no idea open on IVZ today. Signed-in readers see the rule each idea runs on, the floor and the exit level the model set and its time limit, and the model's closed ideas on IVZ with their outcomes. A free account is enough.